Bloomberg Law Reports
Anti‐Commercial Bribery Laws in China and Their Enforcement in the Pharmaceutical Industry
November 2010
Anti‐commercial bribery laws have a huge impact on the daily business operation of companies in China. At present, relevant laws and regulations in China are very general and vague and, as a result, enforcement agencies at local levels have a great deal of discretion in determining what types of activities constitute commercial bribery, and what penalties will be imposed.
得意分野
Suggested News & Insights
Bay Area General Counsel RoundtableThursday, September 24, 2026Sidley Secures Presidential Pardon for Pro Bono Client Jonathan LongSeptember 11, 202622 Sidley Lawyers Named to 2027 Lawdragon 500 Leading Litigators in AmericaSeptember 11, 2026SEC Proposes to Rescind Investment Adviser Pay-to-Play RuleSeptember 10, 2026Planning for the Impact of FinCEN’s Corporate Transparency Act RollbackSeptember 9, 2026Permission to Speak (and a Reason To): FinCEN and Banking Agencies Clarify SAR Confidentiality Rules for Customer Communications About Fraud and Account ClosuresSeptember 8, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory